business

PwC will drop cover for weight-loss drugs from employee health plans

Financial Times · May 1, 2026, 4:00 AM · Also reported by 2 other sources

Big Four accountancy balks at high cost of medication it says has become ‘cultural phenomenon’

Read full story on Financial Times → More top stories

Also covered by

CNBC FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies CNBC More than 20,000 people are taking Eli Lilly's weight loss pill Foundayo, CEO says

Aggregated and edited by the Scoop newsroom. We surface news from Financial Times alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

PwC will drop cover for weight-loss drugs from employee health plans

Also covered by

More in business